ArticleChemical science2026
MAPLE: a machine-learning force-field-native platform for automated reaction modeling and enzyme design.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluating Mechanical-Embedding ML/MM for Predicting Mutation Effects in Chorismate Mutase Catalysis.Journal of chemical theory and computation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Machine-learning force fields (MLFFs) are reshaping computational chemistry and biology by delivering near-quantum mechanical accuracy at a computational cost comparable to conventional force fields, enabling applications in biomolecular simulation, catalysis, and materials science. However, despite these advances, a unified and automated computational platform enabling the broader application of MLFFs is still lacking. Here, we present MAPLE (MAchine learning Potential for Landscape Exploration), a computational toolkit specially developed for MLFF-based molecular modeling, featuring a tailored software framework and parallelized algorithms for large-scale and versatile molecular modeling tasks. We demonstrated the robustness and usability of MAPLE through systematic benchmarking of state-of-the-art reactive MLFFs and applications to multiple biocatalytic scenarios, highlighting its capability for fast yet accurate simulation of catalytic reactions. By integrating accurate and efficient MLFFs with parallelized algorithms in a highly optimized and flexible software framework, MAPLE serves as a next-generation, physically informed, machine-learning-driven molecular modeling platform with broad applicability to rational catalyst design and drug discovery.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.